Researchers found spinal disinhibition in people with fibromyalgia, adding new clues about the role of central pain ...
The Centers for Medicare and Medicaid Services (CMS) has approved the implants for New Technology Add-on Payment (NTAP).
Positive results from its Phase III STEER study mean Novartis could boost sales of its OAV101 IT drug for spinal muscular ...
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...
NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's ...
The ARC-EX stimulator, recently approved by the FDA, makes it easier for the spinal cord to hear what the brain wants to do ...
A new study found that high-frequency stimulation reduced spasticity, and improved patients' ability to walk after spinal ...
The FDA has granted 510 (k) clearance to an expandable lateral lumbar interbody system. U.S. Court–Middle District Florida ...
The drug was compared to a sham control, a procedure designed to mimic the administration of an experimental medicine that doesn’t deliver the active treatment. Spinal muscular atrophy occurs ...
Novartis AG said a new experimental medicine improved motor function in children with a form of spinal muscular atrophy, the devastating disorder targeted by its gene therapy Zolgensma ...
Novartis AG said a new experimental medicine improved motor function in children with a form of spinal muscular atrophy, the devastating disorder targeted by its gene therapy Zolgensma, in an advanced ...